Short answer
Avantor Inc (AVTR) filed an 8-K current report with the SEC on August 27, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Benoit Gourdier, Executive Vice President, Bioscience and Medtech Products, departs Avantor after October 14, 2026.
Avantor Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Benoit Gourdier, Executive Vice President, Bioscience and Medtech Products, departs Avantor after October 14, 2026
- Transition period supports segment integration activities before leadership exit
- Severance benefits contingent on employment and compliance through October 14, 2026
- Benefits materially consistent with Avantor’s Executive Severance and Change in Control Plan
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Avantor Inc 8-K filings
Get the next AVTR 8-K as it lands
Follow AVTR for push alerts, or ask the research agent what this filing means.